Novartis closes Swiss, Chinese centers in research revamp

ZURICH (Reuters) - Novartis said on Wednesday it was shuttering research centers in Switzerland and China, part of the Swiss drug maker's bid to trim some costly locations and centralize control over its drug discovery programs.